| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 86,342,715 | 82,368,987 | 72,722,124 | | Cost of Revenue | 60,443,707 | 56,189,662 | 48,575,157 | | | Gross Profit | 25,899,008 | 26,179,325 | 24,146,967 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 13,799,553 | 12,637,482 | 12,257,665 | | Non Recurring | 190,310 | 360,861 | (205,967) | | Others | 4,743,641 | 4,626,379 | 4,085,008 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,165,505 | 8,554,603 | 8,010,260 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (524,408) | (329,930) | (271,982) | | Earnings Before Interest And Taxes | 6,641,097 | 8,224,674 | 7,938,964 | | Interest Expense |
-
|
-
| 656,189 | | Income Before Tax | 6,641,097 | 8,224,674 | 7,282,775 | | Income Tax Expense | 2,734,818 | 3,443,640 | 3,045,932 | | Minority Interest |
-
|
-
| (295,747) | | | | Net Income From Continuing Ops | 3,999,319 | 4,941,580 | 3,923,932 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 3,999,319 | 4,941,580 | 3,923,932 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,999,319 | $4,941,580 | $3,923,932 |
|
1.00% Nasdaq 0.00%
Income Statement
